Jad Bsat

482 total citations
3 papers, 68 citations indexed

About

Jad Bsat is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Jad Bsat has authored 3 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Genetics, 1 paper in Pathology and Forensic Medicine and 1 paper in Oncology. Recurrent topics in Jad Bsat's work include Chronic Lymphocytic Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (1 paper) and Vascular Tumors and Angiosarcomas (1 paper). Jad Bsat is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Lymphoma Diagnosis and Treatment (1 paper) and Vascular Tumors and Angiosarcomas (1 paper). Jad Bsat collaborates with scholars based in United States. Jad Bsat's co-authors include David C. Fisher, Jennifer R. Brown, Caron A. Jacobson, Matthew S. Davids, Robert Redd, Eric D. Jacobsen, Ann S. LaCasce, Philippe Armand, Robin Joyce and Malek Faham and has published in prestigious journals such as Blood and British Journal of Haematology.

In The Last Decade

Jad Bsat

3 papers receiving 67 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jad Bsat United States 3 64 45 33 17 11 3 68
R. Andrew Harkins United States 4 45 0.7× 20 0.4× 27 0.8× 11 0.6× 7 0.6× 7 69
Noel Laudi United States 4 36 0.6× 14 0.3× 43 1.3× 10 0.6× 9 0.8× 6 56
Alfonso Martín Carnicero Spain 4 37 0.6× 41 0.9× 10 0.3× 8 0.5× 11 1.0× 10 69
Gloria Margiotta Casaluci Italy 5 72 1.1× 34 0.8× 60 1.8× 9 0.5× 18 1.6× 11 99
Dan Kristensen Denmark 4 39 0.6× 33 0.7× 35 1.1× 24 1.4× 10 0.9× 6 83
Abderrazak El Yamani France 4 43 0.7× 28 0.6× 36 1.1× 6 0.4× 12 1.1× 6 55
Tommi Salmi United States 5 75 1.2× 86 1.9× 17 0.5× 8 0.5× 24 2.2× 11 96
Elżbieta Iskierka‐Jazdzewska Poland 7 84 1.3× 71 1.6× 36 1.1× 11 0.6× 21 1.9× 25 110
Yufu Lin China 3 35 0.5× 50 1.1× 22 0.7× 6 0.4× 18 1.6× 10 81
S. Stilgenbauer Germany 5 50 0.8× 56 1.2× 18 0.5× 8 0.5× 10 0.9× 19 71

Countries citing papers authored by Jad Bsat

Since Specialization
Citations

This map shows the geographic impact of Jad Bsat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jad Bsat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jad Bsat more than expected).

Fields of papers citing papers by Jad Bsat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jad Bsat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jad Bsat. The network helps show where Jad Bsat may publish in the future.

Co-authorship network of co-authors of Jad Bsat

This figure shows the co-authorship network connecting the top 25 collaborators of Jad Bsat. A scholar is included among the top collaborators of Jad Bsat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jad Bsat. Jad Bsat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Davids, Matthew S., Haesook T. Kim, Danielle M. Brander, et al.. (2017). A Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients. Blood. 130. 496–496. 8 indexed citations
2.
Armand, Philippe, Robert Redd, Jad Bsat, et al.. (2016). A phase 2 study of Rituximab‐Bendamustine and Rituximab‐Cytarabine for transplant‐eligible patients with mantle cell lymphoma. British Journal of Haematology. 173(1). 89–95. 46 indexed citations
3.
Davids, Matthew S., Haesook T. Kim, Danielle M. Brander, et al.. (2016). Initial Results of a Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients. Blood. 128(22). 3243–3243. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Andrew Harkins Breakdown of academic impact, for papers by Noel Laudi Breakdown of academic impact, for papers by Alfonso Martín Carnicero Breakdown of academic impact, for papers by Gloria Margiotta Casaluci Breakdown of academic impact, for papers by Dan Kristensen Breakdown of academic impact, for papers by Abderrazak El Yamani Breakdown of academic impact, for papers by Tommi Salmi Breakdown of academic impact, for papers by Elżbieta Iskierka‐Jazdzewska Breakdown of academic impact, for papers by Yufu Lin Breakdown of academic impact, for papers by S. Stilgenbauer
Rankless by CCL
2026